Skip to main content
News

Pharma Tech Outlook names us as Top 10 European CRO

By October 9, 2021November 28th, 2021No Comments

Pharma Tech Outlook names us as Top 10 European CRO

We are proud to announce that OPTIMAPHARM has been recognized in Pharma Tech Outlook special edition on CRO Europe 2018, wherein we are named one of the Top 10 CRO’s in Europe.

Industry
recognition

We are proud to announce that OPTIMAPHARM has been recognized in Pharma Tech Outlook special edition on CRO Europe 2018, wherein we are named one of the Top 10 CRO’s in Europe.

As the CRO industry continues to experience change and adaption, it is without a doubt that clinical trials are becoming increasingly complex and costly. Several emerging trends indicate that there are numerous factors that will continue to define and redefine the role of CRO’s. Pharma Tech Outlook’s distinguished panel has selected the Top 10 CRO’s in Europe 2018, evaluating and recognizing competency to provide efficient plus cost-effective solutions and services to the industry.

Both the Founders of OPTIMAPHARM and their Chief BD Officer discuss OPTIMAPHARM’s in-depth understanding of the regions where they operate, and recognize that the strength of the company stems from its career pathway and culture of teamwork that focuses on high performance.

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs

Optimapharm